Alta Life Sciences invests in Inbiomotion
Alta Life Sciences has led an investment round for Barcelona-based Inbiomotion, a biotech company specialising in diagnostics for breast cancer.
More on Early-stage
Novo Seeds, Ysios Capital lead €51m round for Adcendo
RA Capital Management, HealthCap and Gilde Healthcare also take part in the round for the biotech startup
Jolt, Tesi et. al in €30m round for Virta
With the funding, the Finnish company will seek to expand into Asia, which it said was one of the largest markets for EV charging alongside Europe and North America
Gyroscope Therapeutics raises $148m in Forbion-led series C
Series-C round for the gene therapy company is led by Forbion’s Growth Opportunities Fund
OpenOcean and Spintop lead €3.6m series-A for Cambri
Lynda Clarizio, former president of Nielsen US Media, joins the board of directors
Latest News
Alpha appoints Zanotelli as director in Italy
In his new role, Livio Zanotelli will focus on identifying new investment opportunities across Italy
CVC sells AR Packaging to trade for $1.45bn
CVC Capital Partners has signed an agreement to sell portfolio company AR Packaging Group to listed company Graphic Packaging Holding Company for $1.45bn.
Neuberger exits Service Med to MedicAir
GP sells its 75% stake in the medical company, controlled via Atlante Private Equity Fund
Sanne rejects Cinven's £1.3bn offer
Cinven's proposal amounts to 830 pence per share, representing a 37.6% premium to Sanne's shares price of 603 pence